MDL to Provide Discovery Informatics Systems to Nikem Research | GenomeWeb

NEW YORK, Dec. 3—MDL Information Systems announced Monday that it will provide software and informatics systems for NiKem Research Srl, the medicinal chemistry spinoff of GlaxoSmithKline’s former R&D center in Milan, Italy.

NiKem will use MDL’s applications in all stages of drug discovery research, including reagent selection, assay design and biological data capture, storage and analysis, chemical data searching, and chemical registration.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.